Key Insights

Highlights

Success Rate

91% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Low Risk

Score: 27/100

Termination Rate

5.3%

1 terminated out of 19 trials

Success Rate

90.9%

+4.4% vs benchmark

Late-Stage Pipeline

11%

2 trials in Phase 3/4

Results Transparency

40%

4 of 10 completed with results

Key Signals

4 with results91% success

Data Visualizations

Phase Distribution

14Total
Not Applicable (5)
Early P 1 (1)
P 1 (4)
P 2 (2)
P 3 (2)

Trial Status

Completed10
Unknown6
Active Not Recruiting2
Terminated1

Trial Success Rate

90.9%

Benchmark: 86.5%

Based on 10 completed trials

Clinical Trials (19)

Showing 19 of 19 trials
NCT04239235Not ApplicableCompletedPrimary

Integrating Support Persons Into Recovery

NCT07022782Not ApplicableActive Not RecruitingPrimary

MEDiterranean Diet-driven Detoxification of OPioid Addicted patiEnts (MED-DOPE)

NCT04325659Phase 2Completed

An Innovative Intervention for OUD Treatment

NCT05299515Not ApplicableCompleted

Peer Activate: Trial of Peer-Delivered Behavioral Activation for Methadone Adherence

NCT05611749Phase 2Terminated

Duloxetine Impact on Postoperative Pain Control and Outcomes

NCT04309565Not ApplicableActive Not RecruitingPrimary

Transitions Clinic Network: Post Incarceration Addiction Treatment, Healthcare, and Social Support

NCT04336293Not ApplicableCompleted

sTMS for Substance Use-disordered Veterans

NCT03685162CompletedPrimary

Observational Study to Evaluate Levomethadone Safety and Effectiveness in Subjects Under Opioid Maintenance Treatment

NCT02696096Phase 3CompletedPrimary

Neuroimaging Predictors of Relapse During Treatment for Opiate Dependence

NCT03394911Phase 3UnknownPrimary

Healthy Adult Male Facial Skin Surface Lipid Pheromone p.o. to Treat Opioid Addiction

NCT00499746Phase 1Completed

The Discriminative Effects of Tramadol in Humans

NCT01188421Phase 1Completed

Medications Development for Drug Abuse Disorders

NCT01873989Phase 1Completed

Testosterone Replacement for Male Opioid Agonist Maintained Patients

NCT02282072Early Phase 1UnknownPrimary

PINS Stimulator System for Deep Brain Stimulation of the Nucleus Accumbens to Treat Severe Opioid Addiction

NCT02866266Unknown

ER/LA Opioid Surveillance for Emergency Department Visits and Hospitalizations for Overdose and Poisoning

NCT02897414Unknown

ER/LA Opioid Analgesics - Surveillance Monitoring of State Medical Examiner Databases

NCT02871232Unknown

Surveillance Monitoring of Opioid Abuse in Poison and Drug Treatment Centers

NCT01590251Phase 1Completed

Yoga for Pain and Opioid Dependence

NCT01008072UnknownPrimary

Ultra-rapid Opiate Detoxification Using Deep Sedation and Prior Oral Buprenorphine Preparation.

Showing all 19 trials

Research Network

Activity Timeline